BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32408169)

  • 1. Structure-Based Identification and Characterization of Inhibitors of the Epilepsy-Associated K
    Cole BA; Johnson RM; Dejakaisaya H; Pilati N; Fishwick CWG; Muench SP; Lippiat JD
    iScience; 2020 May; 23(5):101100. PubMed ID: 32408169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting K
    Cole BA; Clapcote SJ; Muench SP; Lippiat JD
    Trends Pharmacol Sci; 2021 Aug; 42(8):700-713. PubMed ID: 34074526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New use for an old drug: quinidine in KCNT1-related epilepsy therapy.
    Liu R; Sun L; Wang Y; Wang Q; Wu J
    Neurol Sci; 2023 Apr; 44(4):1201-1206. PubMed ID: 36437393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Epilepsy of Infancy With Migrating Focal Seizures: Identification of
    Mao X; Bruneau N; Gao Q; Becq H; Jia Z; Xi H; Shu L; Wang H; Szepetowski P; Aniksztejn L
    Front Cell Neurosci; 2020; 14():1. PubMed ID: 32038177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K
    Gertler TS; Cherian S; DeKeyser JM; Kearney JA; George AL
    Neurobiol Dis; 2022 Jun; 168():105713. PubMed ID: 35346832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies.
    M Qunies A; A Emmitte K
    Pharm Pat Anal; 2022 Mar; 11(2):45-56. PubMed ID: 35369761
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Iraci N; Carotenuto L; Ciaglia T; Belperio G; Di Matteo F; Mosca I; Carleo G; Giovanna Basilicata M; Ambrosino P; Turcio R; Puzo D; Pepe G; Gomez-Monterrey I; Soldovieri MV; Di Sarno V; Campiglia P; Miceli F; Bertamino A; Ostacolo C; Taglialatela M
    J Med Chem; 2024 Jun; 67(11):9124-9149. PubMed ID: 38782404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum.
    Bonardi CM; Heyne HO; Fiannacca M; Fitzgerald MP; Gardella E; Gunning B; Olofsson K; Lesca G; Verbeek N; Stamberger H; Striano P; Zara F; Mancardi MM; Nava C; Syrbe S; Buono S; Baulac S; Coppola A; Weckhuysen S; Schoonjans AS; Ceulemans B; Sarret C; Baumgartner T; Muhle H; Portes VD; Toulouse J; Nougues MC; Rossi M; Demarquay G; Ville D; Hirsch E; Maurey H; Willems M; de Bellescize J; Altuzarra CD; Villeneuve N; Bartolomei F; Picard F; Hornemann F; Koolen DA; Kroes HY; Reale C; Fenger CD; Tan WH; Dibbens L; Bearden DR; Møller RS; Rubboli G
    Brain; 2021 Dec; 144(12):3635-3650. PubMed ID: 34114611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular switch in RCK2 triggers sodium-dependent activation of K
    Cole BA; Kalli AC; Pilati N; Muench SP; Lippiat JD
    Biophys J; 2024 Apr; ():. PubMed ID: 38605520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.
    Dilena R; DiFrancesco JC; Soldovieri MV; Giacobbe A; Ambrosino P; Mosca I; Galli MA; Guez S; Fumagalli M; Miceli F; Cattaneo D; Darra F; Gennaro E; Zara F; Striano P; Castellotti B; Gellera C; Varesio C; Veggiotti P; Taglialatela M
    Neurotherapeutics; 2018 Oct; 15(4):1112-1126. PubMed ID: 30112700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of the First Orally Available, Selective K
    Griffin AM; Kahlig KM; Hatch RJ; Hughes ZA; Chapman ML; Antonio B; Marron BE; Wittmann M; Martinez-Botella G
    ACS Med Chem Lett; 2021 Apr; 12(4):593-602. PubMed ID: 33859800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Patients With KCNT1-Related Epilepsy Responding to Phenobarbital and Potassium Bromide.
    Datta AN; Michoulas A; Guella I; ; Demos M
    J Child Neurol; 2019 Oct; 34(12):728-734. PubMed ID: 31208268
    [No Abstract]   [Full Text] [Related]  

  • 13. KCNT1 Channel Blockers: A Medicinal Chemistry Perspective.
    Di Matteo F; Mancuso F; Turcio R; Ciaglia T; Stagno C; Di Chio C; Campiglia P; Bertamino A; Giofrè SV; Ostacolo C; Iraci N
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38931004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels.
    Qunies AM; Spitznagel BD; Du Y; Peprah PK; Mohamed YK; Weaver CD; Emmitte KA
    Molecules; 2024 May; 29(11):. PubMed ID: 38893312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of
    Hill SF; Jafar-Nejad P; Rigo F; Meisler MH
    Front Neurosci; 2023; 17():1282201. PubMed ID: 37901435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Epilepsy-Associated KCNT1 Mutation Enhances Excitability of Human iPSC-Derived Neurons by Increasing Slack K
    Quraishi IH; Stern S; Mangan KP; Zhang Y; Ali SR; Mercier MR; Marchetto MC; McLachlan MJ; Jones EM; Gage FH; Kaczmarek LK
    J Neurosci; 2019 Sep; 39(37):7438-7449. PubMed ID: 31350261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligonucleotide therapy for KCNT1 encephalopathy.
    Burbano LE; Li M; Jancovski N; Jafar-Nejad P; Richards K; Sedo A; Soriano A; Rollo B; Jia L; Gazina EV; Piltz S; Adikusuma F; Thomas PQ; Kopsidas H; Rigo F; Reid CA; Maljevic S; Petrou S
    JCI Insight; 2022 Dec; 7(23):. PubMed ID: 36173683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report.
    Takase C; Shirai K; Matsumura Y; Watanabe T; Watanabe A; Hirasawa-Inoue A; Mizuguchi T; Matsumoto N; Sugai K; Hayashi M
    Brain Dev; 2020 Sep; 42(8):607-611. PubMed ID: 32505479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular characterization of
    McTague A; Nair U; Malhotra S; Meyer E; Trump N; Gazina EV; Papandreou A; Ngoh A; Ackermann S; Ambegaonkar G; Appleton R; Desurkar A; Eltze C; Kneen R; Kumar AV; Lascelles K; Montgomery T; Ramesh V; Samanta R; Scott RH; Tan J; Whitehouse W; Poduri A; Scheffer IE; Chong WKK; Cross JH; Topf M; Petrou S; Kurian MA
    Neurology; 2018 Jan; 90(1):e55-e66. PubMed ID: 29196579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Functional Properties, Physiological Roles, Channelopathy and Pharmacological Characteristics of the Slack (KCNT1) Channel.
    Zhang Q; Liu Y; Xu J; Teng Y; Zhang Z
    Adv Exp Med Biol; 2021; 1349():387-400. PubMed ID: 35138624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.